200 related articles for article (PubMed ID: 3096767)
1. Long term studies on almitrine bismesylate in COPD patients.
Bourgouin-Karaouni D; Mercier J; Prefaut C
Eur J Respir Dis Suppl; 1986; 146():695-701. PubMed ID: 3096767
[TBL] [Abstract][Full Text] [Related]
2. Almitrine bismesylate: a long-term placebo-controlled double-blind study in COAD--Vectarion International Multicentre Study Group.
Voisin C; Howard P; Ansquer JC
Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():169s-182s. PubMed ID: 3318971
[TBL] [Abstract][Full Text] [Related]
3. A one year double blind follow-up of blood gas tensions and haemodynamics in almitrine bismesylate therapy.
Préfaut C; Bourgouin-Karaouni D; Ramonatxo M; Michel FB; Macabies J
Eur Respir J; 1988 Jan; 1(1):41-50. PubMed ID: 2896600
[TBL] [Abstract][Full Text] [Related]
4. Vectarion International Multicentre Study (VIMS): a long term double blind placebo controlled trial in COLD patients.
Sadoul P
Eur J Respir Dis Suppl; 1983; 126():357-61. PubMed ID: 6373344
[TBL] [Abstract][Full Text] [Related]
5. Pattern of breathing and gas exchange following oral almitrine bismesylate in patients with chronic obstructive pulmonary disease.
Stradling JR; Nicholl CG; Cover D; Davies EE; Hughes JM; Pride NB
Eur J Respir Dis Suppl; 1983; 126():255-64. PubMed ID: 6373340
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of almitrine bismesylate on pulmonary gas exchange in COPD.
Melot C; Naeije R; Hallemans R; Mols P; Lejeune P
Eur J Respir Dis Suppl; 1983; 126():249-54. PubMed ID: 6586439
[TBL] [Abstract][Full Text] [Related]
7. [Pulmonary hemodynamic monitoring in chronic respiratory insufficiency treated with almitrine bismesilate for 4 months in a double-blind study].
Bourgouin-Karaouni D; Ramonatxo M; Michel FB; Macabies J; Prefaut C
Rev Mal Respir; 1984; 1(4):245-50. PubMed ID: 6505362
[TBL] [Abstract][Full Text] [Related]
8. Effect of almitrine bismesylate on arterial blood gases and ventilatory drive in patients with severe chronic airflow obstruction and bilateral carotid body resection.
de Backer W; Bogaert E; Van Maele R; Vermeire P
Eur J Respir Dis Suppl; 1983; 126():239-42. PubMed ID: 6426993
[TBL] [Abstract][Full Text] [Related]
9. Acute and chronic effects of low dose almitrine bismesylate in the treatment of chronic bronchitis and emphysema.
Winkelmann BR; Leinberger H; Hertrich FF; Rapp W; Dieterich HA; Ansquer JC
Eur J Med; 1992 Dec; 1(8):469-81. PubMed ID: 1341206
[TBL] [Abstract][Full Text] [Related]
10. The role of almitrine bismesylate in acute respiratory failure.
Lambropoulos S; Chatzipappas A; Tsekos G; Tsantoulis K
Eur J Respir Dis Suppl; 1986; 146():657-61. PubMed ID: 3465586
[TBL] [Abstract][Full Text] [Related]
11. Evolution of peripheral nerve function in hypoxaemic COPD patients taking almitrine bismesylate: a prospective long-term study.
Lerebours G; Senant J; Moore N; Arnaud F; David P; Ozenne G; Nouvet G
Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():203s-206s. PubMed ID: 2825867
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of almitrine bismesylate on oxygenation during wakefulness and sleep in chronic obstructive pulmonary disease.
Gothe B; Cherniack NS; Bachand RT; Szalkowski MB; Bianco KA
Am J Med; 1988 Mar; 84(3 Pt 1):436-44. PubMed ID: 2894764
[TBL] [Abstract][Full Text] [Related]
13. The acute effect of a single oral dose of 200 mg almitrine on gas exchange in patients with chronic obstructive bronchitis and emphysema, bronchial asthma and lung fibrosis.
Magnussen H; Radenbach D; Kiwull-Schöne H
Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():211s-214s. PubMed ID: 3690032
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic importance and tolerance of coated 50 mg Vectarion tablets (almitrine bismesylate) at a dosage of 100 mg/day. Study of blood gas, clinical and biological results after a year of long-term treatment].
Ansquer JC; Bertrand A; Blaive B; Charpin J; Chrétien J; Decroix G; Kalb JC; Lissac J; Michel FB; Morère P
Rev Mal Respir; 1985; 2 Suppl 1():S61-7. PubMed ID: 2870549
[TBL] [Abstract][Full Text] [Related]
15. Effects of almitrine bismesylate on chemosensitivity in patients with chronic airways obstruction.
Stanley NN; Pieczora JA; Pauly N
Eur J Respir Dis Suppl; 1983; 126():233-7. PubMed ID: 6426992
[TBL] [Abstract][Full Text] [Related]
16. [The first Italian clinical experience with almitrine bismesylate].
Grassi V; Bottino G; Blasi A; Grassi C
Rev Mal Respir; 1985; 2 Suppl 1():S53-60. PubMed ID: 2870548
[TBL] [Abstract][Full Text] [Related]
17. Dose-response and pharmacokinetic study with almitrine bismesylate after single oral administrations in COPD patients.
Bury T; Jeannot JP; Ansquer JC; Radermecker M
Eur Respir J; 1989 Jan; 2(1):49-55. PubMed ID: 2495983
[TBL] [Abstract][Full Text] [Related]
18. Effects of almitrine bismesylate on arterial blood gases in patients with chronic obstructive pulmonary disease and moderate hypoxaemia: a multicentre, randomised, double-blind, placebo-controlled study.
Górecka D; Sliwiński P; Pałasiewicz G; Pachocki R; Zieliński J;
Respiration; 2003; 70(3):275-83. PubMed ID: 12915747
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological properties of almitrine bismesylate.
Lockhart A
Eur J Respir Dis Suppl; 1983; 126():225-31. PubMed ID: 6586437
[TBL] [Abstract][Full Text] [Related]
20. [Almitrine per os in the therapy of chronic obstructive bronchopneumopathies].
Seignalet C; Préfaut C; Gonzales C; Michel FB
Rev Fr Mal Respir; 1980; 8(6):627-33. PubMed ID: 7027375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
